Additionally, there were no significant associations with the risk of tinnitus when comparing patients with no anti-TNFα therapy use with those who used either AB (hdPS-adjusted HR [95% CI]: 1.00 [0.79, 1.28]) or FP (1.13 [0.79, 1.62]) anti-TNFα therapy (Figure S2). Here, TNF is linked to Tinnitus.